The myth of the normal, average human brain--the ICBM experience: (1) subject screening and eligibility.
In the course of developing an atlas and reference system for the normal human brain throughout the human age span from structural and functional brain imaging data, the International Consortium for Brain Mapping (ICBM) developed a set of "normal" criteria for subject inclusion and the associated exclusion criteria. The approach was to minimize inclusion of subjects with any medical disorders that could affect brain structure or function. In the past two years, a group of 1685 potential subjects responded to solicitation advertisements at one of the consortium sites (UCLA). Subjects were screened by a detailed telephone interview and then had an in-person history and physical examination. Of those who responded to the advertisement and considered themselves to be normal, only 31.6% (532 subjects) passed the telephone screening process. Of the 348 individuals who submitted to in-person history and physical examinations, only 51.7% passed these screening procedures. Thus, only 10.7% of those individuals who responded to the original advertisement qualified for imaging. The most frequent cause for exclusion in the second phase of subject screening was high blood pressure followed by abnormal signs on neurological examination. It is concluded that the majority of individuals who consider themselves normal by self-report are found not to be so by detailed historical interviews about underlying medical conditions and by thorough medical and neurological examinations. Recommendations are made with regard to the inclusion of subjects in brain imaging studies and the criteria used to select them.
Mazziotta
John C
JC
Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. mazz@loni.ucla.edu
Woods
Roger
R
Iacoboni
Marco
M
Sicotte
Nancy
N
Yaden
Kami
K
Tran
Mary
M
Bean
Courtney
C
Kaplan
Jonas
J
Toga
Arthur W
AW
D001921:Brain / Q000033:anatomy & histology* / Q000502:physiology*; D001927:Brain Diseases / Q000453:epidemiology*; D002140:California / Q000453:epidemiology; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000592:standards* / Q000706:statistics & numerical data*; D018579:Patient Selection; D015995:Prevalence; D012016:Reference Values; D015203:Reproducibility of Results; D012647:Self-Assessment; D012680:Sensitivity and Specificity
Stroke. 2004 Aug;35(8):1857-61
15218158
Ann Intern Med. 1984 Sep;101(3):355-69
6235763
J Am Med Inform Assoc. 2001 Sep-Oct;8(5):401-30
11522763
Stroke. 2006 Apr;37(4):1109-12
16497982
Neurology. 2004 Mar 23;62(6):849-50
15037680
J Clin Hypertens (Greenwich). 2005 Feb;7(2):102-9
15722655
Stroke. 2003 Feb;34(2):392-6
12574548
J Psychiatr Res. 1975 Nov;12(3):189-98
1202204
Science. 2006 Feb 10;311(5762):783-4
16469905
Cereb Cortex. 2006 Aug;16(8):1225-31
16251504
Cephalalgia. 2004 Jan;24(1):52-3
14687013
Stroke. 2003 May;34(5):1126-9
12690219
N Engl J Med. 2007 Nov 8;357(19):1928-38
17989385
J Neurol Sci. 2006 Jan 15;240(1-2):81-4
16256141
Neuroimage. 1995 Jun;2(2):89-101
9343592
Philos Trans R Soc Lond B Biol Sci. 2001 Aug 29;356(1412):1293-322
11545704
Ann Neurol. 2008 May;63(5):652-7
18409192
Neurology. 2006 Jun 13;66(11):1622-3
16769931
Arch Gen Psychiatry. 1991 Nov;48(11):1022-5
1747017
Brain. 2005 Sep;128(Pt 9):2068-77
16006538
Hum Brain Mapp. 1994;1(3):210-20
24578041
N Engl J Med. 2007 Nov 1;357(18):1821-8
17978290
JAMA. 2004 Jan 28;291(4):427-34
14747499
N Engl J Med. 2008 May 29;358(22):2316-7
18509119
Cephalalgia. 2004 Jan;24(1):12-7
14687007